October, 2012

iSonea Files FDA Submission for Over-the-Counter SonoSentryâ„¢

September, 2012

2012 Annual Report

Letter to Eligible Shareholders on Rights Issue

Letter to Ineligible Shareholders on Rights Issue

iSonea Announces Fully Underwritten Renounceable Rights Issue to Raise $4M

Appendix 3B: application for quotation of additional securities and agreement

Prospectus: Offer to Eligible Shareholders

Letter to Option Holders

iSonea App Now Free

August, 2012

Preliminary Final Report

Bruce Mathieson Becomes Cornerstone Investor of iSonea

Application for Quotation of Additional Securities and Agreement

Change of Director’s Interest Notice



Contact Us


For business inquiries:
iSonea Limited
P.O. Box 990
Millersville, Maryland 21108-9998
Email: [email protected]

For product inquiries or technical support:
iSonea Limited
1716 Ord Way
Oceanside, California 92056
Tel. +1 760.297.6055
Email: [email protected]

In Australia:
iSonea Limited
Suite 1, 1233 High Street
Armadale, Victoria, AU 3143
+61(0)3 9864 4837

© 2012 iSonea (formerly Karmelsonix) Ltd| Disclaimer, Terms and Conditions, Copyright and Intellectual Property.

BlackFin Processor
BlackFin® Processor
KarmelSonix ISO Certification
ISO Certification 2003
US Food & Drug Administration

US Food & Drug Administration
Australian Government

Australian Government
Therapeutic Goods Administration

CE Certification

CE Certification